Trial intelligence / Profile preview

Pregabalin for Trigger Points in MPS with Fibromyalgia

NCT04600037Completed

Sponsor
Fatih Sultan Mehmet Training and Research Hospital
Start
Apr 2014
Primary completion
Jul 2014
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of pregabalin in myofascial pain syndrome (MPS) (2 arms), sponsored by Fatih Sultan Mehmet Training and Research Hospital. Primary endpoints: Visual Analog Scale at 3 months, Pressure Pain Threshold at 3 months and 2 more. Started Apr 2014; status: completed.

02

Drugs

pregabalin
03

Conditions

myofascial pain syndrome (MPS)

Beyond the preview

Go deeper on NCT04600037.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04600037.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call